Literature DB >> 22740970

Detection of methylation of the RAR-β gene in patients with non-small cell lung cancer.

Xudong Zhao1, Nianfei Wang, Mingjun Zhang, Shaoli Xue, Kaihu Shi, Zhendong Chen.   

Abstract

The aim of this study was to detect methylation of the RAR-β gene in tissues from non-small cell lung cancer (NSCLC) patients. The methylation of the RAR-β gene in DNA from 80 cases with NSCLC and corresponding non-malignant tissues was tested using methylation-specific polymerase chain reaction (PCR; MSP). The results showed that the total frequency of RAR-β methylation was significantly higher in lung cancer tissues compared to the corresponding non-malignant tissues (57.5 vs. 17.5%) (P<0.01). However, no significant difference was found in various clinical stages and types of lung cancer (P>0.05). A significant difference was observed in the various pathological types (P<0.05). RAR-β gene methylation is closely correlated with the development process of NSCLC, particularly squamous cell carcinoma.

Entities:  

Year:  2011        PMID: 22740970      PMCID: PMC3362501          DOI: 10.3892/ol.2011.527

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  20 in total

Review 1.  DNA methylation as a marker for the past and future.

Authors:  Toshikazu Ushijima; Takeshi Nakajima; Takao Maekita
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

2.  Clinical application of methylation specific-polymerase chain reaction in serum of patients with gastric cancer.

Authors:  Hisashi Ikoma; Daisuke Ichikawa; Ikoma Daito; Tani Nobuyuki; Hiroshi Koike; Kazuma Okamoto; Toshiya Ochiai; Yuji Ueda; Hisakazu Yamagishi; Eigo Otsuji
Journal:  Hepatogastroenterology       Date:  2007 Apr-May

3.  Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer.

Authors:  Hans J Grote; Viola Schmiemann; Helene Geddert; Ulrich P Rohr; Rainer Kappes; Helmut E Gabbert; Alfred Böcking
Journal:  Int J Cancer       Date:  2005-09-20       Impact factor: 7.396

4.  RARbeta2 specificity in mediating RA inhibition of growth of lung cancer-derived cells.

Authors:  A Toulouse; J Morin; P A Dion; B Houle; W E Bradley
Journal:  Lung Cancer       Date:  2000-05       Impact factor: 5.705

5.  Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.

Authors:  Keiichi Fujiwara; Nobukazu Fujimoto; Masahiro Tabata; Kenji Nishii; Keitaro Matsuo; Katsuyuki Hotta; Toshiyuki Kozuki; Motoi Aoe; Katsuyuki Kiura; Hiroshi Ueoka; Mitsune Tanimoto
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

6.  Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis.

Authors:  Brian R Vuillemenot; Leah C Pulling; William A Palmisano; Julie A Hutt; Steven A Belinsky
Journal:  Carcinogenesis       Date:  2003-12-04       Impact factor: 4.944

7.  Signalling with retinoids in the human lung: validation of new tools for the expression study of retinoid receptors.

Authors:  Stéphane Poulain; Stéphanie Lacomme; Shyue-Fang Battaglia-Hsu; Stanislas du Manoir; Lydia Brochin; Jean-Michel Vignaud; Nadine Martinet
Journal:  BMC Cancer       Date:  2009-12-04       Impact factor: 4.430

8.  Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.

Authors:  Sonata Jarmalaite; Annamaria Kannio; Sisko Anttila; Juozas R Lazutka; Kirsti Husgafvel-Pursiainen
Journal:  Int J Cancer       Date:  2003-10-10       Impact factor: 7.396

9.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

10.  Fenretinide-induced apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid receptor beta dependent.

Authors:  Pengli Bu; Yu-Jui Yvonne Wan
Journal:  BMC Cancer       Date:  2007-12-31       Impact factor: 4.430

View more
  4 in total

1.  MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer.

Authors:  Tonghui Cai; Xiaoying Guan; Hongyan Wang; Ying Fang; Jie Long; Xiaobin Xie; Yajie Zhang
Journal:  Oncol Lett       Date:  2018-02-14       Impact factor: 2.967

2.  Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy.

Authors:  Mi Jeong Kim; Guo Chen; Gabriel L Sica; Xingming Deng
Journal:  Cancer Biol Ther       Date:  2020-12-18       Impact factor: 4.742

Review 3.  Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review.

Authors:  Xiaoyun Song; Kang Shi; Shi-Jie Zhou; Da-Ping Yu; Zhidong Liu; Yi Han
Journal:  Drug Des Devel Ther       Date:  2016-04-06       Impact factor: 4.162

Review 4.  Association between Retinoic acid receptor-β hypermethylation and NSCLC risk: a meta-analysis and literature review.

Authors:  Yan Li; De-Guo Lu; Ying-Mei Ma; Hongxiang Liu
Journal:  Oncotarget       Date:  2017-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.